Inhibition of serum response factor as a new strategy to overcome resistance to enzalutamide in prostate cancer. (October 2020) - Watson, W.; Gonzalez, C.; Russell, N.; Azam, H.; Corey, E.; Morrissey, C.; Gallagher, W.; Prencipe, M.